Raffa Wealth Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
Raffa Wealth Management's KRYS Position: Q3 2026 in Review
Raffa Wealth Management held its Krystal Biotech (KRYS) position steady in Q3 2026 at 2 shares worth $665. The position accounts for ﹤0.01% of the portfolio, ranked #1129.
Raffa Wealth Management first reported a position in KRYS in Q2 2026 and has held it in 2 quarters since. The position peaked at $743 in Q2 2026. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- Raffa Wealth Management held 2 shares of Krystal Biotech worth $665 as of Q3 2026.
- Raffa Wealth Management left its Krystal Biotech share count unchanged in Q3 2026.
- Krystal Biotech made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1129 holding.
- Raffa Wealth Management first reported a position in Krystal Biotech in Q2 2026 and has held it in 2 quarters since.
- Raffa Wealth Management's Krystal Biotech position peaked at $743 in Q2 2026.
- 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.